98%
921
2 minutes
20
Purpose: To retrospectively review a case of stent-graft infection that presented as continued aneurysm expansion after endoluminal repair.
Case Report: A 75-year-old man with an asymptomatic 6.1-cm abdominal aortic aneurysm (AAA) was treated with a Talent stent-graft, which was complicated by postimplantation syndrome. At 1 year, a secondary intervention was performed for migration with type I endoleak. Despite the absence of a demonstrable endoleak thereafter, the AAA continued to expand until it was 9 cm in diameter and symptomatic. At this stage, 6 months after the secondary procedure, the graft was explanted and an axillobifemoral graft inserted. Propionibacterium acnes was cultured from all specimens of thrombus, aortic wall, and graft. The patient recovered and was asymptomatic until his death from myocardial infarction 6 months after discharge.
Conclusions: Stent-graft infection may be a cause of unexplained endotension. Special culture techniques may be required to identify the infecting organism. Prophylactic antibiotics against skin organisms should be considered for all implantations and arterial diagnostic and therapeutic procedures traversing a stent-graft.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1583/05-1646.1 | DOI Listing |
Medicine (Baltimore)
September 2025
Department of Ultrasound, Hangzhou Women's Hospital, Hangzhou, Zhejiang Province, P. R. China.
Rationale: Sepsis following hysteroscopy is an rare complication, with current evidence suggesting that routine prophylactic antibiotic administration may not be warranted. However, this does not imply that we should disregard vigilance regarding the potential occurrence of severe infections post-hysteroscopy.
Patient Concerns: A 27-year-old female underwent hysteroscopic resection of retained products of conception after incomplete medical abortion.
Front Cell Infect Microbiol
September 2025
Laboratory of Jessica Galloway-Peña, Texas A&M University, Department of Veterinary Pathobiology, Interdisciplinary Graduate Program in Genetics and Genomics, College Station, TX, United States.
Introduction: Acute myeloid leukemia (AML) patients are highly susceptible to infection. Moreover, prophylactic and empirical antibiotic treatment during chemotherapy disrupts the gut microbiome, raising the risk for antibiotic-resistant (AR) opportunistic pathogens. There is limited data on risk factors for AR infections or colonization events in treated cancer patients, and no predictive models exist.
View Article and Find Full Text PDFBull Cancer
September 2025
Direction des soins, centre hospitalier de Brive, 2, boulevard du Dr-Verlhac, 19100 Brive, France. Electronic address:
Multiple myeloma is a haematologic malignancy of the bone marrow with an increasing incidence, primarily affecting an elderly and frail population. It benefits from innovative treatments that have been shown to extend patient survival. However, 2% of patients die from infections during the first year of treatment, despite the availability of prophylactic treatments.
View Article and Find Full Text PDFEur J Obstet Gynecol Reprod Biol
September 2025
Division of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, Pisa, Italy.
Aim: Vaginal natural orifice transluminal endoscopic surgery (vNOTES) combines vaginal and laparoscopic techniques and is increasingly used in gynecologic surgery. Given the lack of standardized guidelines for antibiotic prophylaxis, this review aims to evaluate infection rates, current prophylactic practices, and recommendations.
Method: A literature search was conducted in PubMed/MEDLINE and the Cochrane Library using Medical Subject Headings (MeSH) and keywords such as "v-NOTES," "infection," "prophylaxis," and "antibiotics".
Ann Plast Surg
September 2025
From the Department of Plastic Surgery, Vanderbilt University Medical Center, Nashville, TN.
Background: The practice of systemic antibiotic prophylaxis to prevent surgical site infection (SSI) in breast surgery remains debated. The aim of this review is to provide a comprehensive overview of the literature evaluating the current evidence on the efficacy of antibiotic prophylaxis in nononcologic breast surgery, including risk-reducing mastectomy, gender-affirming mastectomy, augmentation, and reduction.
Methods: A literature search of PubMed and Cochrane databases of 1990-2025 was conducted to identify studies evaluating antibiotic prophylaxis and SSI outcomes in nononcologic breast surgery.